AURA - Aura Biosciences, Inc.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 7.22

Open

$ 7.28

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 7.05 - $ 7.29

52 Week Range

$ 5.99 - $ 13.50

Volume

116,066

Average Volume

Market Cap

286.06M

Beta (5Y Monthly)

$ 1.33

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-27-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-15-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-23-2022	12-31-2021	10-K
10	11-24-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Recap: Aura Biosciences Q4 Earnings
03/27/2024 13:25:06

Aura Biosciences Inc Files For Mixed Shelf...
03/27/2024 12:18:49

Aura Biosciences' Cash And Cash Equivalent...
03/27/2024 11:15:25

Aura Biosciences FY 2023 EPS $(1.93) Misse...
03/27/2024 11:14:26

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate of $(...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
01/09/2024 13:06:02

BTIG Maintains Buy on Aura Biosciences, Lo...
12/08/2023 17:43:47

BTIG analyst Robert Hazlett maintains Aura Biosciences (NASDAQ:AURA) with a Buy and lowers the price target from $38 to $21.

Aura Biosciences Has Dosed The First Patie...
12/07/2023 13:04:18

JMP Securities Maintains Market Outperform...
11/10/2023 19:40:33

JMP Securities analyst Jonathan Wolleben maintains Aura Biosciences (NASDAQ:AURA) with a Market Outperform and lowers the pr...

Over $13M Bet On This Energy Stock? Check ...
11/10/2023 13:52:06

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

Aura Biosciences Q3 EPS $(0.48) Beats $(0....
11/09/2023 22:33:37

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0....

why-aura-biosciences-stock-hit-a-new-52-week-low-today

Why Aura Biosciences Stock Hit A New 52-We...
11/07/2023 20:17:44

Aura Biosciences Inc (NASDAQ: AURA) shares are trading lower by 34.7% to $7.18 Tuesday afternoon after the company announced pr...

why-sanmina-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Sanmina Shares Are Trading Lower By Ar...
11/07/2023 18:10:11

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spe...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
11/07/2023 17:31:21

why-alteryx-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket

Why Alteryx Shares Are Trading Higher By A...
11/07/2023 13:28:51

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reporte...

12 Health Care Stocks Moving In Tuesday's ...
11/07/2023 13:06:23

Sanmina, Adtran, Ameresco And Other Big St...
11/07/2023 11:15:51

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market tradin...

Aura Biosciences Prices Public Offering Of...
11/07/2023 07:05:04

Aura Biosciences Announces Proposed Public...
11/06/2023 22:43:48

Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
11/06/2023 21:31:02

Aura Biosciences Receives FDA Agreement Un...
11/06/2023 20:01:36

Positive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing Phase 2 Clinical Trial with S...